Topical Statin Wound Composition for Infected Complex Wounds

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing wound healing compositions are inadequate for addressing complex wound healing issues such as infection, abnormal healing, and complications arising from factors like age, infection, poor nutrition, and immunosuppression.

Innovation Solution

A topical wound treatment composition is formulated by mixing dry powder contents of a pharmaceutical container with petrolatum, a water-washable-ointment, or a cream type vehicle, incorporating 5 mg to 200 mg of one or more statins, optionally with naltrexone, antibiotics, or antifungal drugs, and additional ingredients like PEG-8, PEG-75, meadowsweet extract, and zinc acetate, which are administered to the target tissue.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing wound healing compositions are used, then basic wound care is provided, but they are inadequate for addressing complex wound healing issues such as infection, abnormal healing, and complications

Engineering Contradiction:
Improveeffectiveness for complex wound healingVSAvoidability to address multiple wound complications
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent combines multiple active ingredients (statins, naltrexone, antibiotics, antifungals) into a single topical composition that can address multiple wound healing complications simultaneously, including infection, inflammation, and abnormal healing processes

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The composition is designed to perform multiple functions: statins promote tissue repair and reduce inflammation, naltrexone modulates immune response, and optional antibiotics/antifungals prevent or treat infections, making it suitable for various complex wound types

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If topical composition with multiple ingredients is formulated, then comprehensive wound treatment is achieved, but formulation complexity increases

Engineering Contradiction:
Improvecomprehensive wound treatment capabilityVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The formulation process is segmented into distinct steps: mixing dry powder contents with petrolatum or water-washable ointment, then incorporating additional ingredients like PEG-8, PEG-75, meadowsweet extract, and zinc acetate in sequence, making the complex formulation process more manageable

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS12521391B2Wound treatments and compositions
Publication Date: 2026.01.13 CMPD LICENSING LLC

AI summary

A method of treating a wound may include topically administering a statin composition including a statin selected from atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, or combination thereof. The statin composition may be administered in an ointment, powder, or liquid format. The method may also include topically administering one or more antimicrobial drugs and/or naltrexone.